Mikko Seppänen

14.2k total citations · 4 hit papers
80 papers, 2.2k citations indexed

About

Mikko Seppänen is a scholar working on Immunology, Epidemiology and Genetics. According to data from OpenAlex, Mikko Seppänen has authored 80 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Immunology, 17 papers in Epidemiology and 15 papers in Genetics. Recurrent topics in Mikko Seppänen's work include Immunodeficiency and Autoimmune Disorders (28 papers), Blood disorders and treatments (11 papers) and Immune Cell Function and Interaction (9 papers). Mikko Seppänen is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (28 papers), Blood disorders and treatments (11 papers) and Immune Cell Function and Interaction (9 papers). Mikko Seppänen collaborates with scholars based in Finland, United States and Sweden. Mikko Seppänen's co-authors include Kathleen E. Sullivan, Troy R. Torgerson, Isabelle Meyts, Christoph Klein, Tomohiro Morio, Stuart G. Tangye, Raz Somech, Helen C. Su, Anne Puel and Capucine Pïcard and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mikko Seppänen

78 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee

2022 569 citations Stuart G. Tangye, Charlotte Cunningham‐Rundles et al. Journal of Clinical Immunology profile →
The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity

2022 244 citations Abderrahmane Moundir, Stuart G. Tangye et al. Journal of Clinical Immunology profile →
Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee

2025 40 citations M. Cecilia Poli, Ivona Aksentijevich et al. PubMed profile →
The 2024 update of IUIS phenotypic classification of human inborn errors of immunity

2025 16 citations Ahmed Aziz Bousfiha, Leïla Jeddane et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikko Seppänen Finland	23	1.4k	539	487	339	309	80	2.2k
Nima Parvaneh Iran	26	1.4k 1.0×	593 1.1×	389 0.8×	296 0.9×	311 1.0×	132	2.1k
Teresa Español Spain	26	1.6k 1.2×	520 1.0×	463 1.0×	477 1.4×	293 0.9×	67	2.3k
Robert P. Nelson United States	26	1.4k 1.0×	488 0.9×	490 1.0×	386 1.1×	352 1.1×	97	2.7k
Ayşe Metìn Türkiye	21	1.4k 1.0×	447 0.8×	244 0.5×	218 0.6×	146 0.5×	84	2.2k
Maria Manuela Rosado Italy	25	1.4k 1.0×	249 0.5×	386 0.8×	268 0.8×	175 0.6×	57	2.6k
Francisco A. Bonilla United States	24	1.7k 1.2×	413 0.8×	426 0.9×	189 0.6×	185 0.6×	60	2.5k
Jiří Litzman Czechia	31	2.1k 1.5×	675 1.3×	349 0.7×	155 0.5×	358 1.2×	105	2.8k
Ikuya Tsuge Japan	24	1.6k 1.1×	382 0.7×	458 0.9×	389 1.1×	96 0.3×	87	3.0k
Ali Akbar Amirzargar Iran	26	1.2k 0.8×	269 0.5×	562 1.2×	451 1.3×	157 0.5×	106	2.3k
Ramsay Fuleihan United States	29	1.8k 1.3×	461 0.9×	277 0.6×	129 0.4×	253 0.8×	89	2.5k

Countries citing papers authored by Mikko Seppänen

Since Specialization

Citations

This map shows the geographic impact of Mikko Seppänen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Seppänen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Seppänen more than expected).

Fields of papers citing papers by Mikko Seppänen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Seppänen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Seppänen. The network helps show where Mikko Seppänen may publish in the future.

Co-authorship network of co-authors of Mikko Seppänen

This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Seppänen. A scholar is included among the top collaborators of Mikko Seppänen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Seppänen. Mikko Seppänen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poli, M. Cecilia, Ivona Aksentijevich, Ahmed Aziz Bousfiha, et al.. (2025). Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. PubMed. 1(1). e20250003–e20250003. 40 indexed citations breakdown →

Hölttä‐Vuori, Maarit, Salla Keskitalo, Markku Varjosalo, et al.. (2025). A TOM1 variant impairs interaction with TOLLIP, autophagosome-lysosome fusion and regulation of innate immunity. Disease Models & Mechanisms. 18(9). 1 indexed citations

Kettunen, K, Pia Laine, Amy L. Stiegler, et al.. (2025). Novel heterozygous SPI1c.538C>T p.(Leu180Phe) variant causes PU.1 haploinsufficiency leading to agammaglobulinemia. Clinical Immunology. 277. 110503–110503.

Bousfiha, Ahmed Aziz, Leïla Jeddane, Abderrahmane Moundir, et al.. (2025). The 2024 update of IUIS phenotypic classification of human inborn errors of immunity. PubMed. 1(1). e20250002–e20250002. 16 indexed citations breakdown →

Karbiener, Michael, Gerhard Kindle, Isabelle Meyts, et al.. (2024). Clinical efficacy of SARS‐CoV‐2 Omicron ‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency. Journal of Medical Virology. 96(6). e29738–e29738. 1 indexed citations

Pesonen, Paula, Minna K. Karjalainen, Marjo‐Riitta Järvelin, et al.. (2023). Low and high serum IgG associates with respiratory infections in a young and working age population. EBioMedicine. 94. 104712–104712. 3 indexed citations

Tuvikene, Jürgen, Anu Planken, Eija Kalso, et al.. (2022). Immune response to a conserved enteroviral epitope of the major capsid VP1 protein is associated with lower risk of cardiovascular disease. EBioMedicine. 76. 103835–103835. 2 indexed citations

Tuovinen, Elina, Sakari Pöysti, Firas Hamdan, et al.. (2022). Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling. Journal of Clinical Immunology. 43(2). 358–370. 4 indexed citations

Vakkilainen, Svetlana, Paula Klemetti, Timi Martelius, et al.. (2021). Pulmonary Follow-Up Imaging in Cartilage-Hair Hypoplasia: a Prospective Cohort Study. Journal of Clinical Immunology. 41(5). 1064–1071. 1 indexed citations

10.

Perazzio, Sandro Félix, Eric J. Allenspach, Kari K. Eklund, et al.. (2020). Behçet disease (BD) and BD‐like clinical phenotypes: NF‐κB pathway in mucosal ulcerating diseases. Scandinavian Journal of Immunology. 92(5). e12973–e12973. 19 indexed citations

11.

Pikkarainen, Sampsa, Timi Martelius, Ari Ristimäki, et al.. (2019). A High Prevalence of Gastrointestinal Manifestations in Common Variable Immunodeficiency. The American Journal of Gastroenterology. 114(4). 648–655. 59 indexed citations

12.

Hannula‐Jouppi, Katariina, Elísabet Einarsdóttir, Outi Elomaa, et al.. (2019). Nagashima-type palmoplantar keratosis in Finland caused by a SERPINB7 founder mutation. Journal of the American Academy of Dermatology. 83(2). 643–645. 12 indexed citations

13.

Rajamäki, Kristiina, Salla Keskitalo, Mikko Seppänen, et al.. (2018). Haploinsufficiency of A20 impairs protein–protein interactome and leads into caspase-8-dependent enhancement of NLRP3 inflammasome activation. RMD Open. 4(2). e000740–e000740. 26 indexed citations

14.

Trotta, Luca, Anna Norberg, Mervi Taskinen, et al.. (2018). Diagnostics of rare disorders: whole-exome sequencing deciphering locus heterogeneity in telomere biology disorders. Orphanet Journal of Rare Diseases. 13(1). 139–139. 10 indexed citations

15.

Sullivan, Kathleen E., Hamid Bassiri, Ahmed Aziz Bousfiha, et al.. (2017). Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies. Journal of Clinical Immunology. 37(7). 650–692. 5 indexed citations

16.

Paakkanen, Riitta, Marja‐Liisa Lokki, Mikko Seppänen, et al.. (2012). Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction. Atherosclerosis. 221(2). 461–466. 25 indexed citations

17.

Norja, Päivi, Kalle Kantola, Kaisa Kemppainen, et al.. (2012). Occurrence of human bocaviruses and parvovirus 4 in solid tissues. Journal of Medical Virology. 84(8). 1267–1273. 18 indexed citations

18.

Kainulainen, Leena, Ville Peltola, Mikko Seppänen, et al.. (2012). C4A deficiency in children and adolescents with recurrent respiratory infections. Human Immunology. 73(5). 498–501. 15 indexed citations

19.

Jarva, Hanna, et al.. (2008). Binding of complement regulators factor H and C4b binding protein to group A streptococcal strains isolated from tonsillar tissue and blood. Microbes and Infection. 10(7). 757–763. 5 indexed citations

20.

Ihanamäki, Tapio, Mikko Seppänen, Marjaana Tiainen, et al.. (2004). Echovirus Type 4 as a Probable Cause of Meningitis Associated with Bilateral Optic Neuritis: A Case Report. Clinical Infectious Diseases. 38(6). e49–e51. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact